Images List Premium Download Classic

Vaccine

Vaccine-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Vaccines and diagnostics for the ehrlichioses
Research Development Foundation
June 15, 2017 - N°20170166628

The present invention concerns vlpt immunoreactive compositions for e. Chaffeensis and compositions related thereto, including vaccines, antibodies, polypeptides, peptides, and polynucleotides. In particular, epitopes for e. Chaffeensis vlpt are disclosed.
Method of treating cancer
Intensity Therapeutics, Inc.
June 15, 2017 - N°20170165369

The invention provides a method for treating cancer using a coadministration strategy that combines local codelivery of a therapeutic agent and an intracellular penetration enhancing agent, and optionally in further combination with local administration of an immunotherapeutic agent, such as a cancer vaccine or nkt agonist. The invention also provides a method for treating cancer using an intracellular penetration enhancing ...
Methods for enhancing the immunostimulation potency of aluminum salt-absorbed vaccines
The Government Of The United States Of America As Reprisented By Secretary Of The Army
June 15, 2017 - N°20170165358

Provided herein are (1) a method of mixing an aluminum salt-adsorbed immunogen with a monophosphoryl lipid a (mpla)-containing liposome (l(mpla)), and (2) the resulting immunogenic composition. The resulting immunogenic composition has an enhanced immunostimulation potency compared with either a composition comprising the uncapsulated immunogen mixed with the l(mpla) or the aluminum salt-adsorbed immunogen alone.
Vaccine Patent Pack
Download + patent application PDFs
Vaccine Patent Applications
Download + Vaccine-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Vaccine-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Human immunodeficiency virus antigens, vectors, compositions, and methods of use thereof
Janssen Vaccines & Prevention B.v.
June 15, 2017 - N°20170165355

Synthetic hiv envelope proteins, vectors and compositions thereof, and methods for inducing protective immunity against human immunodeficiency virus (hiv) infection are described. Viral expression vectors encoding the synthetic hiv envelope proteins can be used in vaccines to provide improved protective immunity against hiv.
Thermostable freeze dried rotavirus vaccine formulation and process to prepare thereof
Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd.
June 15, 2017 - N°20170165354

The present invention relates to a thermostable freeze dried rotavirus vaccine formulation and the process of preparing the same. More specifically the present invention discloses multivalent thermostable liquid, powder or cake based rotavirus vaccine formulation prepared using the freeze drying process, such that the said vaccine formulation possess improved heat-stability, easy to use and transport and highly affordable thereby meeting ...
Novel vaccines against multiple subtypes of influenza virus
The Trustees Of The University Of Pennsylvania
June 15, 2017 - N°20170165353

An aspect of the present invention is directed towards dna plasmid vaccines capable of generating in a mammal an immune response against a plurality of influenza virus subtypes, comprising a dna plasmid and a pharmaceutically acceptable excipient. The dna plasmid is capable of expressing a consensus influenza antigen in a cell of the mammal in a quantity effective to elicit ...
Vaccine Patent Pack
Download + patent application PDFs
Vaccine Patent Applications
Download + Vaccine-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Vaccine-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Serologic correlates of protection against bacillus anthracis infection
The United States Of America, As Represented By The Secretary, Department Of Health And Human
June 15, 2017 - N°20170165344

Regions of bacillus anthracis protective antigen are provided representing epitopes recognized by antibodies in subjects that have acquired immunity to bacillus anthracis infection. The recognition of these epitopes correlates with autoimmunity in a subject. Also provided are vaccines that include at least one of these epitopes that when administered to a subject provide improved acquired immunity.
Method of reducing titers of antibodies specific for a therapeutic agent
Duke University
June 15, 2017 - N°20170165316

The present invention relates, in general, to a method of treating patients undergoing enzyme replacement therapy (ert) or other therapy involving the administration of a proteinaceous therapeutic agent as well gene replacement therapy with non-viral or viral vectors, or other therapeutic modality or modalities, used alone or in combination, which involve the administration of exogenous substances for potential therapeutic benefit, ...
Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders
Affiris Ag
June 08, 2017 - N°20170158744

A method of treating a synucleinopathy with a peptide (c)dqpvlpd (seq id no: 59), (c)dmpvlpd (seq id no: 60), (c)dspvlpd (seq id no: 61), (c)dqpvlpdn (seq id no: 64), (c)dmpvlpdn (seq id no: 65), (c)dspvlpdn (seq id no: 66), (c)hdrpvtpd (seq id no: 70), (c)drpvtpd (seq id no: 71), (c)dvpvlpd (seq id no: 72), (c)dtpvypd (seq id no: 73), (c)...
Compositions and methods for treatment of celiac disease
Immusant, Inc.
June 08, 2017 - N°20170158743

The invention provides agents and vaccines for treating and diagnosing celiac disease. In particular, the present invention provides a combination of three peptides that are useful for treating and diagnosing celiac disease in a large proportion of patients.
Sulfated-glycolipids as adjuvants for vaccines
National Research Council Of Canada
June 08, 2017 - N°20170158728

A synthetic charged glycolipid is described comprising a sulfated saccharide group covalently linked to the tree sn-1 hydroxyl group of the glycerol backbone of an archaeal core lipid via a beta linkage. The synthetic charged glycolipids include compounds of formula i wherein n is 0 or 1; r is hydrogen or hydroxyl; and y is hydrogen or a sulfate group, at least ...
Novel compounds
National Research Council Of Canada
June 08, 2017 - N°20170158724

And pharmaceutically acceptable salts and tautomers thereof, compositions, combinations and medicaments containing said compounds and processes for their preparation. The invention also relates to the use of said compounds, combinations, compositions and medicaments, in the treatment of diseases in which modulation of sting (stimulator of interferon genes) is beneficial, for example inflammation, allergic and autoimmune diseases, infectious diseases, cancer, pre-cancerous ...
Compositions and methods of enhancing immunogenicity of polysaccharide protein conjugates
Kanvax Biopharmaceuticals Ltd
June 08, 2017 - N°20170157241

The present invention provides compositions and methods for enhancing immunogenicity of polysaccharide antigens. Immunogenic compositions and vaccines comprising polysaccharide-protein conjugates comprising a chimeric carrier protein having a universal epitope are provided. Methods of preparing the compositions, and methods for treating or preventing bacterial infections are further provided. The compositions and methods are useful for enhancing immune response in young children, ...
Vaccine Patent Pack
Download + patent application PDFs
Vaccine Patent Applications
Download + Vaccine-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Vaccine-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Hpv vaccine formulations comprising aluminum adjuvant and methods of producing same
Merck Sharp & Dohme Corp.
June 08, 2017 - N°20170157238

The invention provides human papillomavirus (hpv) antigen formulations which show increased antigen stability. More specifically, the invention provides stable hpv formulations comprising hpv virus-like particles (vlps) bound to an aluminum salt adjuvant and further comprise a combination of sucrose and mannitol. The vaccine formulations of the invention are stable following freeze-thaw and freeze-drying. Also provided are lyophilized and frozen hpv ...
Vaccines and compositions against streptococcus pneumoniae
Children's Medical Center Corporation
June 08, 2017 - N°20170157234

Streptococcus pneumoniae is a major health concern, especially in very young, elderly, or immunocompromised patients. The present disclosure provides, inter alia, certain highly effective vaccines and pharmaceutical compositions in streptococcus pneumoniae. The antigens may be used therapeutically or prophylactically.
Therapeutic cancer vaccine
Cadila Pharmaceuticals Ltd.
June 08, 2017 - N°20170157231

The present invention relates to vaccine(s) comprising cancer cells expressing antigen(s), excipients, optionally adjuvant wherein the said antigen(s) is expressed on contacting the said cancer cell with p38 inducer, for use in treatment of cancer. The vaccine composition induces specific immune response against homologous and heterologus cancer cells of the tissue/organ. The invention also provides method ...
Genetically engineered swine influenza virus and uses thereof
The United States Of America, As Represented By The Secretary Of Agriculture
June 01, 2017 - N°20170151324

The present invention relates, in general, to attenuated swine influenza viruses having an impaired ability to antagonize the cellular interferon (ifn) response, and the use of such attenuated viruses in vaccine and pharmaceutical formulations. In particular, the invention relates to attenuated swine influenza viruses having modifications to a swine ns1 gene that diminish or eliminate the ability of the ns1 ...
Chimeric pestiviruses
Zoetis Services Llc
June 01, 2017 - N°20170151321

The present invention relates to chimeric pestiviruses having utility as immunogenic compositions and vaccines. Also described herein are methods and kits for treating or preventing the spread of bovine viral diarrhea virus infection, as well as methods and kits for differentiating between vaccinated and wild-type infected animals.
Vaccines for human papilloma virus and methods for using the same
Inovio Pharmaceuticals, Inc.
June 01, 2017 - N°20170151320

Improved anti-hpv immunogens and nucleic acid molecules that encode them are disclosed. Immunogens disclosed include those having consensus hpv39 e6e7 and hpv45 e6e7. Pharmaceutical composition, recombinant vaccines comprising dna plasmid and live attenuated vaccines are disclosed as well methods of inducing an immune response in an individual against hpv are disclosed.
Anti-mycoplasma spp. subunit vaccine
Agricultural Technology Research Institute
June 01, 2017 - N°20170151318

Provided in the present invention are anti-mycoplasma spp. Subunit vaccines, especially proteins suitable for being used as the active ingredient of the mycoplasma spp. Subunit vaccines, and a vaccine prepared therefrom. Upon experimenting, it is confirmed that the proteins can elicit an immune response having sufficient strength to avoid the infection of mycoplasma spp. In pigs. The vaccine can comprise ...
Potency test for vaccine formulations
Agricultural Technology Research Institute
May 25, 2017 - N°20170146506

The invention relates to certain methods for the determination of an antigen content of a first antigen in a mixture comprising two or more antigens. The invention also relates to a potency test for an antigen in a combination vaccine. The method allows the determination of the antigen content in a mixture additionally comprising antibodies that are capable of binding ...
Loading